Design and evaluation of novel barrier layer technologies for controlling venlafaxine hydrochloride release from tablet dosage form

References

• Pillay V, Moodley K, Choonara Y, et al. Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery. Int J Mol Sci 2012;13:18–43
   PubMedGoogle Scholar
• Kuotsu K, Mandal A, Biswas N, et al. Drug delivery system based on chronobiology – a review. J Control Release 2010;147:314–325
   PubMedGoogle Scholar
• Lanao JM, Maderuelo C, Zarzuelo A. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release 2011;154:2–19
   PubMedGoogle Scholar
• Gundu R, Dabre R, Jain G. A device for the manufacture of a dosage form with a hole and method of manufacture. Patent WO 2011/110989 A1, 15 Sept 2011
   Google Scholar
• Gundu R, Dabre R, Jain G. Pharmaceutical composition for modified delivery of actives Patent WO 2011/080716A2, 7 July 2011
   Google Scholar
• Zhu L-M, Yu D-G, Branford-White C, et al. Novel drug delivery devices for providing linear release profiles fabricated by 3DP. Int J Pharm 2009;370:160–166
   PubMedGoogle Scholar
• Kim C. Controlled release from triple layer, doughnut-shaped tablets with enteric polymers. AAPS PharmSciTech 2005;6:E429–E436
   PubMedGoogle Scholar
• Danckwerts M, Sundy E. A novel compression-coated doughnut-shaped tablet design for zero-order sustained release. Eur J Pharm Sci 2004;22:477–485
   PubMedGoogle Scholar
• Cheng K, Zhu J, Song X, et al. Studies of hydroxypropylmetylcellulose doughnut-shaped tablets. Drug Dev Ind Pharm 1999;25:1067–1071
   PubMed Web of Science ®Google Scholar
• Kim C. Release kinetics of coated, doughnut-shaped tablets for water soluble drugs. Eur J Pharm Sci 1999;7:237–242
   PubMed Web of Science ®Google Scholar
• Kim C. Compressed doughnut shaped tablets with zero order release kinetics. Pharm Res 1995;12:1045–1048
   PubMed Web of Science ®Google Scholar
• Cleave J. Some geometrical considerations concerning the design of tablets. J Pharm Pharmacol 1965;17:698–702
   PubMed Web of Science ®Google Scholar
• Chopra S. Procise: drug delivery systems based on geometric configuration. In: Rathbone M, Hadgraft J, Roberts M, eds. Modified-release drug delivery technology. New York: Marcel Dekker; 2003;35–48
   Google Scholar
• Efentakis M, Naseef H, Vlachou M. Two and three layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs. Drug Dev Ind Pharm 2010;36:903–916
   PubMed Web of Science ®Google Scholar
• Shajahan A, Poddar S. A flexible technology for modified release of drugs: multi layered tablets. J Control Release 2004;97:393–405
   PubMedGoogle Scholar
• Park JS, Shim JY, Park JS, et al. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles. Drug Dev Ind Pharm 2011;37:664–672
   PubMed Web of Science ®Google Scholar
• Efentakis M, Peponaki C. Formulation study and evaluation of matrix and three-layer tablet sustained drug delivery systems based on carbopols with isosorbide mononitrate. AAPS PharmSciTech 2008;9:917–923
   PubMed Web of Science ®Google Scholar
• Patel V, Prajapati B, Patel M. Formulation, evaluation and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech 2007;8:E1–E8
   PubMedGoogle Scholar
• Fassihi1 R, Ritschel W. Multiple-layer, direct compression controlled release system: in vitro and in vivo evaluation. J Pharm Sci 1993;82:750–754
   PubMedGoogle Scholar
• Vergnault G, Grenier P, Lauretta M, Conte U. Hydrophilic/lipophilic polymeric matrix dosage formulation. US Patent No. 7927624. 19 Apr 2011
   Google Scholar
• Pollock PE, Westrup J, Yates DJ. Novel formulation of Ropinirole. US Patent Application No.2007/0059365 A1. 15 Mar 2007
   Google Scholar
• Colombo P, Colombo G, Cahyadi C. Geometric release systems: principles, release mechanisms, kinetics, polymer science, and release-modifying material. In: Wilson C, Crowley P, eds. A text book of controlled release in oral drug delivery. New York: Springer; 2011:221–237
   Google Scholar
• An industry roundtable. Multilayer tablets: key challenges and trends. Pharm Tech Solid Excipients 2012;36:s22–s33
   Google Scholar
• Conte U, Arsizio B, Manna A, Colombo P. System for the controlled – rate release of active substances. US Patent No. 4839177; 13 June 1989
   Google Scholar
• Conte U, Arsizio B, Manna A, Colombo P. Tablets with controlled – rate release of drug substances. US Patent No. 5422123; 6 June 1995
   Google Scholar
• Gohel M, Bariya S. Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose. Pharm Dev Technol 2009;14:650–658
   PubMed Web of Science ®Google Scholar
• Physicians’ desk reference. PDR Network, LLC, 66th edition 2012:3020–3030
   Google Scholar
• Sherman D, Clark J, Lamer J, White S. Extended release formulation of venlafaxine hydrochloride. US 6274171B1; 14 Aug 2001
   Google Scholar
• Sherman D, Clark J, Lamer J, White S. Extended release formulation of venlafaxine hydrochloride. US 6419958B2; 16 Jul2002
   Google Scholar
• Rabiskova M, Dvorackova K, Masteikova R, et al. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets. Drug Dev Ind Pharm 2009;35:930–940
   PubMedGoogle Scholar
• Levina M, Siahboomi AR. The influence of excipients on drug release from hydroxylpropyl methylcellulose matrix. J Pharm Sci 2004;93:2746–2754
   PubMed Web of Science ®Google Scholar
• Mitchell S, Balwinski K. Investigation of hypromellose particle size effects on drug release from sustained release hydrophilic matrix tablets. Drug Dev Ind Pharm 2007;33:952–958
   PubMed Web of Science ®Google Scholar
• Siepmann J, Muschert S, Siepmann F, Leclercq B. Dynamic and static curing of ethyl cellulose:PVA-PEG graft copolymer film coatings. Eur J Pharm Biopharm 2011;78:455–461
   PubMedGoogle Scholar
• Custred M, Vesey C, Siahboomi R. The influence of post coating thermal treatment on film properties and drug release from ethylcellulose barrier membrane coating systems. Poster reprint of colorcon at AAPS annual meeting. November 2008. Available from: http://www.colorcon.com/literature/marketing/mr/Extended%20Release/Surelease/English/poster_AAPS_2008_thermal_barrier.pdf [last accessed 7 Apr 2013]
   Google Scholar
• Miller R, Vadas E. The physical stability of tablets coated using an aqueous dispersion of ethylcellulose. Drug Dev Ind Pharm 1984;10:1565–1585
   Web of Science ®Google Scholar
• Kollidon® SR. BASF, Technical Information, The chemical company, 03_030728e-08; July 2011; 1–12
   Google Scholar
• Guidance for industry – Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on bio pharmaceutics classification system. USFDA, CDER, Aug 2000
   Google Scholar
• Wan L, Heng P, Wong L. The effect of hydroxypropylmethylcellulose on water penetration into a matrix system. Int J Pharm 1991;73:111–116
   Web of Science ®Google Scholar
• Miranda A, Millan M, Caraballo I. Study of the critical points of hydroxypropylmethylcellulose matrices for controlled drug delivery. Int J Pharm 2006;311:75–81
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Peppas N. Observation of swelling process and diffusion front position during swelling in hydroxypropylmethylcellulose matrices containing a soluble drug. J Control Release 1999;61:83–91
   PubMed Web of Science ®Google Scholar
• Gao P, Skoug J, Nixon P, et al. Swelling of hydroxypropylmethylcellulose matrix tablets. 2. Mechanistic study of the influence of the formulation variables on matrix performance and drug release. J Pharm Sci 1996;85:732–740
   PubMed Web of Science ®Google Scholar
• Tahara K, Yamamoto K, Nishihata T. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J Control Release 1995;35:59–66
   Web of Science ®Google Scholar
• Colombo P, Bettini R, Santi P, Peppas N. Swellable matrices for controlled drug delivery: gel-layer behavior, mechanisms and optimal performance. Pharm Sci Technol Today 2000;3:198–204
   PubMedGoogle Scholar
• Todd P, Hote-Gaston J, Sheick M. Comparison of swelling, erosion and gel strength of polyethylene oxide and hypromellose. Poster presented at annual meeting and exposition of AAPS, Atlanta, Georgia, 16–20 November 2008. Available from: http://www.colorcon.com/literature/marketing/mr/Extended%20Release/METHOCEL/English/AAPS2008_L′Hote-Gaston_Technical_Paper_2008-11-13.pdf [last accessed 7 Apr 2013]
   Google Scholar
• Sakellariou P, Rowe R. Interactions in cellulose derivative films for oral drug delivery. Prog Polym Sci 1995;20:889–942
   Google Scholar
• Porter S. Controlled release film coatings based on ethylcellulose. Drug Dev Ind Pharm 1989;15:1495–1521
   Web of Science ®Google Scholar
• Sakellariou P, Rowe R, White E. A study of the leaching/retention of water-soluble polymers in blends with ethylcellulose using torsional braid analysis. J Control Release 1988;7:147–157
   Web of Science ®Google Scholar
• Dias V, Ambudkar V, Steffenino R, et al. The influence of pore-former on drug release from ethylcellulose coated multiparticulates. Technical bulletin published by Colorcon Asia Pvt. Ltd., Verna, Goa, India and Colorcon, Harleysville, PA, USA, 2010. Available from: http://www.colorcon.com/literature/marketing/mr/Extended%20Release/ETHOCEL/Chinese/The%20Influence%20of%20Pore-Former%20on%20Drug%20Release%20from%20Ethylcellulose%20Coated%20Multiparticulates [last accessed 7 Apr 2013]
   Google Scholar
• Durig T, Harcum W, Kinsey B, et al. Water-soluble cellulose ethers as release modulators for ethylcellulose coatings on multiparticulates. Ashland specialty ingredients PTR-036-1:2011
   Google Scholar
• Levina M, Vuong H, Siahboomi R. The effect of hypromellose as a pore-former on drug release from aqueous ethylcellulose film-coated dipyridamole-loaded non-pareil beads. Poster reprint controlled release society. July 2007. Available from: http://www.colorcon.com/literature/marketing/mr/Extended%20Release/Surelease/English/hypromellose_pore_former.pdf [last accessed 7 Apr 2013]
   Google Scholar
• Wilson K, Crossman E. The influence of tablet shape and pan speed on intra-tablet film coating uniformity. Drug Dev Ind Pharm 1997;23:1239–1243
   Web of Science ®Google Scholar
• Shen E, Farrell T, Siahboomi. Effects of core tablet size on the functionality of aqueous delayed release coatings as measured by SEM and LIBS. Technical bulletin published by Colorcon Inc. Global headquarters, Harleysville, PA USA, 2010. Available from: http://www.colorcon.com/literature/marketing/mr/Delayed%20Release/Acryl-EZE/English/R6253_11110v5_Layout%201.pdf [last accessed 7 Apr 2013]
   Google Scholar
• Moore J, Flanner H. Mathematical comparison of dissolution profiles. Pharm Technol 1996;20:64–74
   Google Scholar
• Guidance for industry. Extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations USFDA, CDER, September 1997
   Google Scholar